Global Non-PVC IV Bags Market Report 2024

The non-PVC IV bags market size has grown strongly in recent years. It will grow from $1.63 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the need for non-toxic materials for medicine packaging, an increase in chemotherapy treatments, a high prevalence of chronic kidney diseases, an increase in unmet healthcare needs, and a rise in the geriatric population.

The non-PVC IV bags market size is expected to see strong growth in the next few years. It will grow to $2.6 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the rising incidence of cancer, the expansion of hospitals and ambulatory centers, increasing patient traffic within healthcare settings, growing government initiatives, and a rising demand for preventative measures against errors. Major trends in the forecast period include infrastructure development within healthcare sectors, the development and availability of modern materials in various designs, technological advances in service quality, demand for advanced containers, and the adoption of single-chambered non-PVC IV bags.

The increasing patient traffic within healthcare settings is expected to drive the growth of the non-PVC IV bags market in the future. Patient traffic refers to the volume of patients seeking medical care or services within a healthcare facility, such as a hospital, clinic, or doctor's office. There is a higher demand for healthcare services and changes in healthcare policies or insurance coverage. Non-PVC IV bags are needed for patients due to concerns about the potential leaching of harmful chemicals from PVC materials into intravenous fluids, minimizing the risk of patient exposure to toxins. For instance, in January 2024, a report published by the National Health Service (NHS), a UK-based publicly funded healthcare system, stated that 1.63 million patients initiated treatment, and over 2.3 million diagnostic tests were conducted in November 2023. This maintained significant pressure on emergency departments nationwide, with more than 2.1 million accident and emergency (A&E) visits and over 547,000 emergency admissions occurring in December 2023. Therefore, the increasing patient traffic within healthcare settings is driving the growth of the non-PVC IV bags market.

Major companies operating in the non-PVC IV bags market are developing innovative products, such as polyolefin film IV containers, for storing and administering fluids and medications. A polyolefin film IV container is a type of intravenous (IV) solution container made from polyolefin film, a plastic material known for its flexibility, durability, and safety in medical applications. For instance, in April 2021, Fresenius Kabi, a Germany-based manufacturer of non-PVC IV bags, launched sodium chloride injection in Freeflex IV bags. The Freeflex IV bag, available in two strengths (1,000 USP units in a 0.9% sodium chloride 500 mL infusion bag and 2,000 USP units in a 0.9% sodium chloride 1,000 mL infusion bag), stands out with its unique design. The Freeflex bag is crafted from a multilayer, polyolefin film container, offering leak-resistant technology and an easy-to-handle design for infusion therapies, streamlining the administration process compared to traditional vials.

In November 2023, Prange Group, a Germany-based company focused on sales and marketing of pharmaceuticals, and Adragos Pharma, a Germany-based contract development and manufacturing organization (CDMO), acquired Fresenius Kabi’s sterile pharmaceutical production site for an undisclosed amount. As a result of the acquisition, the company aims to expand its existing production network in Europe, North America, and Japan. Through this transaction, Fresenius Kabi will enter into a long-term supply agreement for products manufactured at the site. Fresenius Kabi is a Germany-based manufacturer of non-PVC IV bags.

Major companies operating in the Non-PVC IV bags market are Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton Dickinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Sealed Air Corporation, Nipro Corporation, ICU Medical Inc., Kraton Corporation, Haemonetics Corporation, JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Persico S.p.a., Angiplast Pvt. Ltd., Fagron Sterile Services, Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH.

North America was the largest region in the non-PVC IV bags market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Non-PVC IV bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the Non-PVC IV bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Non-PVC IV bags are intravenous bags that do not contain polyvinyl chloride (PVC) and are used in healthcare settings to administer fluids, medications, and nutrients directly into a person's vein. These bags are commonly used in hospitals and emergency medical services due to their resistance to chemicals, heat, and UV light, which ensures the quality and stability of IV fluids.

The primary types of non-PVC IV bags are single-chamber and multi-chamber. Single-chamber non-PVC IV bags contain only one compartment and are made from materials other than PVC, such as ethylene vinyl acetate, polypropylene, copolyester ether, and others. They can contain both frozen and liquid mixtures for various applications, including chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection, and more. These bags are utilized by various end-user industries, including hospitals, clinics, emergency service centers, ambulatory surgical centers, and others.

The non-PVC IV bags market research report is one of a series of new reports that provides non-PVC IV bags market statistics, including non-PVC IV bags industry global market size, regional shares, competitors with a non-PVC IV bags market share, detailed non-PVC IV bags market segments, market trends and opportunities, and any further data you may need to thrive in the non-PVC IV bags industry. This non-PVC IV bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-PVC IV bags market consists of sales of sterilizable IV film or bag, IV tubing, and infusion administration sets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.